Global Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)

BioGaia

Market Cap: SEK 10.2b

A healthcare company, provides probiotic products worldwide.

Guilin Sanjin Pharmaceutical

Market Cap: CN¥8.0b

Engages in the research, production, and sale of traditional Chinese and natural medicines in China.

Tsumura

Market Cap: JP¥334.2b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Tong Ren Tang Technologies

Market Cap: HK$6.0b

Manufactures and sells Chinese medicine products in Mainland China and internationally.

Shandong Wit Dyne HealthLtd

Market Cap: CN¥7.0b

Engages in the pharmaceutical business in China.

Biofarm

Market Cap: RON 660.2m

Engages in the manufacture and sale of medicines in Romania.

Chengdu Kanghua Biological Products

Market Cap: CN¥8.1b

Chengdu Kanghua Biological Products Co., Ltd.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.6b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Tempo Scan Pacific

Market Cap: Rp11.6t

Engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.

Faes Farma

Market Cap: €1.2b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.

Teyi Pharmaceutical GroupLtd

Market Cap: CN¥3.7b

Engages in the research and development, production, and sale of Chinese patent medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China.